A phase I dose-escalation trial of stereotactic body radiotherapy using 4 fractions for patients with localized prostate cancer

被引：0
作者：
Takuro Kainuma
Shogo Kawakami
Hideyasu Tsumura
Takefumi Satoh
Ken-ichi Tabata
Masatsugu Iwamura
Kazushige Hayakawa
Hiromichi Ishiyama
机构：
[1] Kitasato University School of Medicine,Department of Radiation Oncology
[2] Kitasato University School of Medicine,Department of Urology
来源：
Radiation Oncology | / 14卷
关键词：
Prostate cancer; Stereotactic body radiotherapy; Dose-escalation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Stereotactic Body Radiotherapy: An Emerging Treatment Approach for Localized Prostate Cancer
    Friedland, Jay L.
    Freeman, Debra E.
    Masterson-McGary, Mary Ellen
    Spellberg, David M.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2009, 8 (05) : 387 - 392
  • [22] Erectile function after stereotactic body radiotherapy for localized prostate cancer
    Dess, Robert T.
    Hartman, Holly E.
    Aghdam, Nima
    Jackson, William C.
    Soni, Payal D.
    Abugharib, Ahmed E.
    Suy, Simeng
    Desai, Neil B.
    Zumsteg, Zachary S.
    Mehra, Rohit
    Morgan, Todd M.
    Feng, Felix Y.
    Hamstra, Daniel A.
    Schipper, Matthew J.
    Collins, Sean P.
    Spratt, Daniel E.
    BJU INTERNATIONAL, 2018, 121 (01) : 61 - 68
  • [23] Stereotactic body radiotherapy for localized prostate cancer – 5-year efficacy results
    Kristiina Vuolukka
    Päivi Auvinen
    Erno Tiainen
    Jan-Erik Palmgren
    Janne Heikkilä
    Jan Seppälä
    Sirpa Aaltomaa
    Vesa Kataja
    Radiation Oncology, 15
  • [24] Stereotactic body radiotherapy for localized prostate cancer-5-year efficacy results
    Vuolukka, Kristiina
    Auvinen, Paivi
    Tiainen, Erno
    Palmgren, Jan-Erik
    Heikkila, Janne
    Seppala, Jan
    Aaltomaa, Sirpa
    Kataja, Vesa
    RADIATION ONCOLOGY, 2020, 15 (01)
  • [25] Long-term Outcomes from a Phase 1 Dose Escalation Study Using Stereotactic Body Radiotherapy for Patients with Low- or Intermediate-risk Prostate Cancer
    Moore, Assaf
    Kollmeier, Marisa A.
    Mcbride, Sean M.
    Toumbacaris, Nicolas
    Zhang, Zhigang
    Lacy-Elsayegh, Ahmed
    Dreyfuss, Alexandra
    Grossman, Craig E.
    Gorovets, Daniel
    Zelefsky, Michael J.
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (04): : 812 - 820
  • [26] Prostate-specific antigen kinetics after hypofractionated stereotactic body radiotherapy for localized prostate cancer
    Kim, H. J.
    Phak, J. H.
    Kim, W. Ch.
    INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 2016, 14 (04): : 297 - 303
  • [27] Incoherent dose-escalation in phase I trials using the escalation with overdose control approach
    Wheeler, Graham M.
    STATISTICAL PAPERS, 2018, 59 (02) : 801 - 811
  • [28] Phase I trial of dose escalation for preoperative stereotactic radiosurgery for patients with large brain metastases
    Murphy, Erin S.
    Yang, Kailin
    Suh, John H.
    Yu, Jennifer S.
    Stevens, Glen
    Angelov, Lilyana
    Vogelbaum, Michael A.
    Barnett, Gene H.
    Ahluwalia, Manmeet S.
    Neyman, Gennady
    Mohammadi, Alireza M.
    Chao, Samuel T.
    NEURO-ONCOLOGY, 2024, 26 (09) : 1651 - 1659
  • [29] ROLE OF INTENSITY-MODULATED RADIOTHERAPY IN REDUCING TOXICITY IN DOSE ESCALATION FOR LOCALIZED PROSTATE CANCER
    Al-Mamgani, Abrahim
    Heemsbergen, Wilma D.
    Peeters, Stephanif T. H.
    Lebesque, Joos V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (03): : 685 - 691
  • [30] Subgroup analysis of patients with localized prostate cancer treated within the Dutch-randomized dose escalation trial
    Al-Mamgani, Abrahim
    Heemsbergen, Wilma D.
    Levendag, Peter C.
    Lebesque, Joos V.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 (01) : 13 - 18
12345